CardiAMP™ Cell Therapy for Heart Failure Trial
Trial details
- Registry ID
- NCT02438306
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| CardiAMP™ Cell Therapy for Heart Failure TrialNCT02438306 | BCDA | Phase 3 | Completed | 2025-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |